Induction of apoptotic cell death by particulate lead chromate: Differential effects of vitamins C and E on genotoxicity and survival

Toxicology and Applied Pharmacology

Volumn 146, Issue 2, 1997, Pages 270-280

  Blankenship, L J ^a   Carlisle, D L ^a   Wise Sr , J P ^a   Orenstein, J M ^a   Dye III, L E ^a   Patierno, S R ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; LEAD CHROMATE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CHO CELL; CHROMOSOME ABERRATION; CONTROLLED STUDY; GENOTOXICITY; NONHUMAN; PARTICULATE MATTER;

EID: 0030810096     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8237     Document Type: Article

References (35)

1. Blankenship L. J., Manning F. C. R., Orenstein J. M., Patierno S. R. Apoptosis is the mode of cell death caused by carcinogenic chromium. Toxicol. Appl. Pharmacol. 126:1994;75-83.
2. Bridgewater L. C., Manning F. C. R., Patierno S. R. Base-specific arrest ofin vitro. Carcinogenesis. 14:1994;2421-2427.
3. Burke T., Fagliano J., Goldoft M., Hazen R. E., Inglewicz R., McKee T. Chromite ore processing residue in Hudson County, New Jersey. Environ. Health Perspect. 92:1991;31-137.
4. Dean R. T., Cheeseman K. H. Vitamin E protects proteins against free radical damage in lipid environments. Biochem. Biophys. Res. Commun. 148:1987;1277-1282.
5. DeFlora S., Bagnasco M., Serra D., Zanacchi P. Genotoxicity of chromium compounds. A review. Mutat. Res. 238:1990;99-172.
6. Deschamps F., Moulin J. J., Wild P., Labriffe H., Haguenoer J. M. Mortality study among workers producing pigments in France. Int. Arch. Occup. Environ. Health. 67:1995;147-152.
7. Edmundson W. F. Chrome ulcers of the skin and nasal septum and their relation to patch testing. J. Invest. Dermatol. 17:1951;17.
8. Glaser U., Hochrainer D., Kloppel H., Oldiges H. Carcinogenicity of sodium dichromate and chromium (VI/III) oxide aerosols inhaled by male Wistar rats. Toxicology. 42:1986;219-232.
9. Hamilton J. W., Wetterhahn K. E. Differential effects of chromium(VI) on constitutive and inducible gene expression in chick embryo liverin vivo. Mol. Carcinog. 2:1989;274-286.
10. IARC, 1980, IARC Monographs on the evaluation of Carcinogenic Risk of Chemicals to Humans: Some Metals and Metallic Compounds, 23, 205, 323, International Agency for Research on Cancer, Lyon, France.
11. IARC, 1990, IARC Monographs on the evaluation of Carcinogenic Risk of Chemicals to Humans, 49, International Agency for Research on Cancer, Lyon, France.
12. Kleinfeld M., Rosso A. Ulcerations of the nasal septum due to inhalation of chromic acid mist. Ind. Med. Surg. 34:1965;242-243.
13. Kwanishi S., Inoue S., Sano S. Mechanism of DNA cleavage-induced by sodium chromate (VI) in the presence of hydrogen peroxide. J. Biol. Chem. 261:1986;5952-5988.
14. Langard S., Vigander T. Occurrences of lung cancer in workers producing chromium pigments. Br. J. Ind. Med. 40:1983;71-74.
15. Levis A. G., Malone F. Cytotoxic and clastogenic effects of soluble chromium compounds on mammalian cell cultures. Br. J. Cancer. 40:1981;523-533.
16. Manning F. C. R., Xu J., Patierno S. R. Transcriptional inhibition by carcinogenic chromate: Relationship to DNA damage. Mol. Carcinog. 6:1992;270-279.
17. Norseth T. The carcinogenicity of chromium. Environ. Health Perspect. 40:1981;121-130.
18. Patierno S. R., Banh D., Landolph J. R. Transformation of C3H10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead chromate but not soluble calcium chromate: Relationship to mutagenesis and internalization of lead chromate particles. Cancer Res. 48:1988;5280-5288.
19. Shi X., Dalal N. S. Chromium (V) and hydroxyl radical formation during the glutathione reductase-catalyzed reduction of chromium(VI). Bichem. Biophys. Res. Commun. 163:1989;627-634.
20. Sorahan T., Burges D. C. L., Waterhouse J. A. H. A mortality study of nickel/chromium platers. Br. J. Ind. Med. 44:1987;250-258.
21. Standeven A. M., Wetterhahn K. E. Chromium (VI) toxicity: Uptake, reduction, and DNA damage. J. Am. Cell. Toxicol. 8:1989;1275-1283.
22. Standeven A. M., Wetterhahn K. E. Ascorbate is the principal reductant of chromium (VI) in rat liver and kidney ultra filtrates. Carcinogenesis. 12:1991;1733-1737.
23. Stearns D. M., Kennedy L. J., Courtney K. D., Giangrande P. H., Phieffer L. S., Wetterhahn K. E. Reduction of chromium (VI) by ascorbate leads to chromium-DNA binding and strand-breaks in vitro. Biochemistry. 34:1995;910-919.
24. Stearns D. M., Wetterhahn K. E. Reaction of chromium (VI) with ascorbate produces chromium (V), chromium (IV), and carbon-based radicals. Chem. Res.Toxicol. 7:1994;219-230.
25. 4. Mol. Pharmacol. 29:1986;606-613.
26. Sugiyama M., Ando A., Ogura R. Effect of vitamin E on survival, glutathione reductase and formation of chromium (V) in Chinese hamster V-79 cells treated with sodium chromate (VI). Carcinogenesis. 10:1989;737-741.
27. Sugiyama M., Tsuzuki K., Ogura R. Effect of ascorbic acid on DNA damage, cytotoxicity, glutathione reductase, and formation of paramagnetic chromium in Chinese hamster V-79 cells treated with sodium chromate (VI). J. Biol. Chem. 266:1991a;3383-3386.
28. Sugiyama M., Lin X., Costa M. Protective effect of vitamin E against chromosomal aberrations and mutation induced by sodium chromate in Chinese hamster V-79 cells. Mutat. Res. 260:1991b;19-23.
29. Sugiyama M. Role of physiological antioxidants in chromium (VI)-induced cellular injury. Free Rad. Biol. Med. 12:1992;397-407.
30. Tsapakos M. J., Wetterhahn K. E. The interaction of chromium with nucleic acids. Chem. Biol. Interact. 46:1983;265-277.
31. Tsuneta H. The concentration of chromium in the tissues of the respiratory tract among chromate workers with lung cancer. Haigan. 18:1978;341-348.
32. U.S. Public Health Service, 1953, Health of Workers in Chromate Producing Industry, U.S. Gov. Printing Office, Washington, DC.
33. Wise J. P., Leonard J. C., Patierno S. R. Clastogenicity of lead particles in hamster and human cells. Mutat. Res. 278:1992;69-79.
34. Wise J. P., Orenstein J. M., Patierno S. R. Inhibition of lead chromate clastogenesis by ascorbate: Relationship to particle dissolution and uptake. Carcinogenesis. 14:1993;429-434.
35. Wise J. P., Stearns D. M., Wetterhahn K. E., Patierno S. R. Cell-enhanced dissolution of carcinogenic lead chromate particles: Role of individual dissolution products in clastogenesis. Carcinogenesis. 15:1994;2249-2254.